J&J/DePuy Charité To Be First Artificial Spinal Disc Reviewed By FDA Panel
This article was originally published in The Gray Sheet
Executive Summary
FDA's Orthopaedic & Rehabilitation Devices Panel will meet June 2 to review a PMA for Johnson & Johnson/DePuy's Charité artificial lumbar disc for degenerative disc disease
You may also be interested in...
Spinal Concepts Warned Over QSR Violations, Unverified Design Changes
Abbott is in the process of integrating wholly-owned subsidiary Spinal Concepts into its quality systems program in order to assure a more systematic approach and greater level of compliance with FDA, according to company reps
Spinal Concepts Warned Over QSR Violations, Unverified Design Changes
Abbott is in the process of integrating wholly-owned subsidiary Spinal Concepts into its quality systems program in order to assure a more systematic approach and greater level of compliance with FDA, according to company reps
J&J/DePuy Charite Artificial Spinal Disc Restores Height By 7.2 MM Average
Johnson & Johnson/DePuy's Charite artificial lumbar disc restores disc space height from an average of 5.7 mm pre-implant to 12.9 mm at 24 months